Table of Contents

December 15, 2025; Volume 22,Issue 12

  1. Aili, Aifeina

    1. Open Access
      Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4/SLC7A11/GSH axis
      Chunya Li, Aifeina Aili, Qingqing Yu, Mu Yang, Qiyuan Feng, Duo Xu, Bo Liu, Jingyao Tu and Xianglin Yuan
      Cancer Biology & Medicine December 2025, 22 (12) 1627-1647; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0275

  2. Bai, Menglin

    1. Open Access
      COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1+CD8+ T cell infiltration in NSCLC
      Lin Ma, Menglin Bai, Yao Wang, Xueying Zhai, Jinming Yu and Xiangjiao Meng
      Cancer Biology & Medicine December 2025, 22 (12) 1537-1543; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0205

  3. Cai, Yiran

    1. Open Access
      From bone marrow to the tumor microenvironment: how neutrophil maturation shapes cancer immunity
      Tao Shi, Yiran Cai, Hanbing Wang and Jia Wei
      Cancer Biology & Medicine December 2025, 22 (12) 1431-1438; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0547

  4. Chan, Cerise Yuen-Ki

    1. Open Access
      Harnessing the STING pathway for HCC treatment
      Carmen Chak-Lui Wong, Cerise Yuen-Ki Chan, Helen Do-Gai Xue and Chun-Ming Wong
      Cancer Biology & Medicine December 2025, 22 (12) 1423-1430; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0434

  5. Chang, Antao

    1. Open Access
      CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway
      Chao Xu, Zekun Li, Yueying Shan, Chunhua She, Yanfang Yang, Tianxing Zhou, Yongjie Xie, Bo Ni, Chenyang Meng, Guangcong Shen, Boyang Fu, Guannan Sheng, Liangliang Wu, Jinlong Pei, Tiansuo Zhao, Song Gao, Hongwei Wang, Chengqi Deng, Kaiyuan Wang, Antao Chang, Chongbiao Huang, Lei Shi, Shengyu Yang, Jun Yu, Jihui Hao and Xiuchao Wang
      Cancer Biology & Medicine December 2025, 22 (12) 1558-1577; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0058

  6. Chen, Cheng

    1. Open Access
      Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy
      Shuyi Hu, Zipeng Wu, Yingying Dai, Xinhong Shi, Qin Hu, Caolu Liu, Yifei Zhu, Ruofan Yu, Jingwen Li, Ying Liu, Tianyi Liu, Lin Lu, Chengyun Yao, Bo Shen, Meiqi Shi, Cheng Chen, Xiaohua Wang and Guoren Zhou
      Cancer Biology & Medicine December 2025, 22 (12) 1544-1552; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0393

  7. Dai, Yingying

    1. Open Access
      Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy
      Shuyi Hu, Zipeng Wu, Yingying Dai, Xinhong Shi, Qin Hu, Caolu Liu, Yifei Zhu, Ruofan Yu, Jingwen Li, Ying Liu, Tianyi Liu, Lin Lu, Chengyun Yao, Bo Shen, Meiqi Shi, Cheng Chen, Xiaohua Wang and Guoren Zhou
      Cancer Biology & Medicine December 2025, 22 (12) 1544-1552; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0393

  8. Deng, Chengqi

    1. Open Access
      CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway
      Chao Xu, Zekun Li, Yueying Shan, Chunhua She, Yanfang Yang, Tianxing Zhou, Yongjie Xie, Bo Ni, Chenyang Meng, Guangcong Shen, Boyang Fu, Guannan Sheng, Liangliang Wu, Jinlong Pei, Tiansuo Zhao, Song Gao, Hongwei Wang, Chengqi Deng, Kaiyuan Wang, Antao Chang, Chongbiao Huang, Lei Shi, Shengyu Yang, Jun Yu, Jihui Hao and Xiuchao Wang
      Cancer Biology & Medicine December 2025, 22 (12) 1558-1577; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0058

  9. Ding, Rui

    1. Open Access
      Comprehensive investigation of the molecular basis of cancer dependencies suggests therapeutic options for breast cancer
      Rui Ding, Zhiming Shao and Tianjian Yu
      Cancer Biology & Medicine December 2025, 22 (12) 1605-1626; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0290

  10. Fan, Lihong

    1. Open Access
      Current status of traditional Chinese medicine in modulating mitochondrial metabolic abnormalities in tumors
      Siyi Ma, Jiarong Li, Bingjie Hao and Lihong Fan
      Cancer Biology & Medicine December 2025, 22 (12) 1439-1454; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0246
« Previous (Pages : 1 2 3 4 5 6 ... 11) Next »
Back to top

In this issue

Cancer Biology & Medicine: 22 (12)
Cancer Biology & Medicine
Vol. 22, Issue 12
15 Dec 2025

Submit

Sign up for alerts